EverCommerce (NasdaqGS:EVCM) Q3 2025 Earnings Call November 06, 2025 05:00 PM ET Speaker0Thank you for standing by, and welcome to EverCommerce's third quarter 2025 earnings call. My name is Jonathan, and I will be your operator for today. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. To ask a question during this session, you'll need to press star 11 on your telephone. If your question has been answered and you'd lik ...

Yelp (NYSE:YELP) Q3 2025 Earnings Call November 06, 2025 05:00 PM ET Speaker2Thank you for standing by. My name is Eric, and I will be your conference operator today. At this time, I would like to welcome everyone to the Q3 2025 Yelp earnings conference call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question-and-answer session. If you would like to ask a question during this time, simply press star followed by the number one on your tel ...

AEye (NasdaqCM:LIDR) Q3 2025 Earnings Call November 06, 2025 05:00 PM ET Speaker2Ladies and gentlemen, thank you for standing by. At this time, I would like to welcome everyone to the AEye Q3 2025 earnings conference call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. If you would like to ask a question during this time, simply press star followed by the number one on your telephone keypad. If you would like to w ...

Karat Packaging (NasdaqGS:KRT) Q3 2025 Earnings Call November 06, 2025 05:00 PM ET Speaker1Good day, and welcome to the Karat Packaging Q3 2025 earnings conference call. All participants will be in a listen-only mode. Should you need assistance, please signal conference specialists by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star then one on your touchtone phone. To withdraw your question, please press ...

Diodes (NasdaqGS:DIOD) Q3 2025 Earnings Call November 06, 2025 05:00 PM ET Speaker3Good afternoon and welcome to Diodes Incorporated's third quarter 2025 financial results conference call. At this time, all participants are in a listen-only mode, and at the conclusion of today's conference call, instructions will be shared for the question-and-answer session. If anyone needs assistance at any time during the conference call, please press the star key followed by the zero on your touch-tone phone, and an ope ...

Microchip (NasdaqGS:MCHP) Q2 2026 Earnings Call November 06, 2025 05:00 PM ET Speaker0Greetings and welcome to the Microchip's Q2 Fiscal 2026 Financial Results Conference call. At this time, all participants are on a listen-only mode. A question-and-answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. As a reminder, this conference is being recorded. It is now my pleasure to introduce your hos ...

MP Materials (NYSE:MP) Q3 2025 Earnings Call November 06, 2025 05:00 PM ET Speaker3Hello, and welcome to the MP Materials Q3 earnings call. We ask that you please hold all questions until the completion of the formal remarks, at which time you will be given instructions for the question-and-answer session. Also, as a reminder, this conference is being recorded. If you have any objections, please disconnect at this time. With that, I would like to turn the call over to Martin Sheehan, Head of Investor Relati ...

eXp World (NasdaqGM:EXPI) Q3 2025 Earnings Call November 06, 2025 05:00 PM ET Speaker4Welcome to the eXp World Holdings Third Quarter 2025 Earnings Fireside Chat via livestream in our metaverse on the web, Frame. My name is Denise Garcia, and I manage investor relations for eXp World Holdings. Today, we will begin our Earnings Fireside Chat with remarks from Leo Pareja, CEO of eXp Realty; Wendy Forsythe, CMO of eXp Realty; Felix Bravo, Managing Director, eXp Realty International; Jesse Hill, Chief Financial ...

Financial Data and Key Metrics Changes - Elutia reported Q3 2025 revenue of $3.3 million, down from $3.6 million in the same quarter last year, but gross margin improved to 55.8% from 49% a year ago [39][40] - Adjusted gross margin, excluding non-cash amortization, was 64% compared to 56% in the prior year [40] - Operating expenses decreased to $7.1 million from $11 million a year ago, resulting in a loss from operations of $5.2 million, down from $9 million [40] Business Line Data and Key Metrics Changes - SimpliDerm revenue increased by 18% from Q2 2025 to $2.4 million, although it was down from the previous year due to various factors [35] - Cardiovascular product sales reached $900,000 in Q3 2025, up 68% year-over-year and 28% sequentially [38] Market Data and Key Metrics Changes - The breast reconstruction market is valued at $1.5 billion, with 162,000 procedures performed annually in the U.S. [11][12] - Post-operative infection rates in breast reconstruction are reported to be between 15%-20%, highlighting a significant unmet medical need [10][11] Company Strategy and Development Direction - Elutia aims to leverage its validated technology platform to address the unmet medical need in breast reconstruction through the development of NXT 41 and NXT 41X products [10][29] - The company plans to utilize its existing commercial infrastructure from SimpliDerm to support the launch of NXT 41 and NXT 41X [49] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's future, emphasizing the importance of the recent sale of the bio-envelope business to Boston Scientific for $88 million, which strengthens the balance sheet and operational efficiency [32][33] - The company is focused on resolving legacy litigation issues, with only six cases remaining from an initial 110, indicating a move towards a cleaner operational slate [42] Other Important Information - The company has a robust manufacturing facility in Gaithersburg, Maryland, which is expected to support the production of NXT 41 and NXT 41X without delays [55] - Elutia has resolved seven legacy litigation cases in the quarter, reducing the total to six remaining cases with an estimated liability of $700,000 [42] Q&A Session Summary Question: Insights from Eliupro's development to commercial rollout - Management highlighted the importance of having a strong team and commercial infrastructure in place, which contributed to Eliupro's successful market entry [46][47] Question: Leveraging SimpliDerm for NXT - The existing relationships and commercial presence from SimpliDerm will be utilized to facilitate the adoption of NXT 41X, as both products target the same customer base [49] Question: Clinical evidence and data generation for NXT - While there is no requirement for clinical data for the 510(k) pathway, the company plans to generate strong clinical evidence to support the product's market adoption [51][53] Question: Manufacturing plans for NXT and 41X - The manufacturing of NXT and 41X will occur in a separate GMP facility, ensuring compliance with regulations and readiness for production [54][55] Question: Current run rate and growth sustainability for cardiovascular business - The cardiovascular business is expected to achieve steady growth, with a current run rate of approximately $1 million per quarter, benefiting from high gross margins [57]

Grindr (NYSE:GRND) Q3 2025 Earnings Call November 06, 2025 05:00 PM ET Speaker1Ladies and gentlemen, thank you for standing by and welcome to Grindr's third-quarter 2025 earnings call. My name is Janine, and I will be your lead operator for today. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question-and-answer session. If you would like to ask a question during this time, simply press star followed by the number one on your telephone keypa ...